JP2004508017A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004508017A5 JP2004508017A5 JP2002512413A JP2002512413A JP2004508017A5 JP 2004508017 A5 JP2004508017 A5 JP 2004508017A5 JP 2002512413 A JP2002512413 A JP 2002512413A JP 2002512413 A JP2002512413 A JP 2002512413A JP 2004508017 A5 JP2004508017 A5 JP 2004508017A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- exon
- depending
- nucleotide sequence
- ugt1a7
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002773 nucleotide Substances 0.000 claims 54
- 125000003729 nucleotide group Chemical group 0.000 claims 54
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 44
- 101710205340 UDP-glucuronosyltransferase 1A7 Proteins 0.000 claims 31
- 102100040213 UDP-glucuronosyltransferase 1A7 Human genes 0.000 claims 29
- 101710008381 UGT1A6 Proteins 0.000 claims 25
- 102100040198 UDP-glucuronosyltransferase 1-6 Human genes 0.000 claims 23
- 150000007523 nucleic acids Chemical class 0.000 claims 16
- 108020004707 nucleic acids Proteins 0.000 claims 13
- 102000039446 nucleic acids Human genes 0.000 claims 13
- 238000000034 method Methods 0.000 claims 11
- 102000016354 Glucuronosyltransferase Human genes 0.000 claims 10
- 108010092364 Glucuronosyltransferase Proteins 0.000 claims 10
- 108700028369 Alleles Proteins 0.000 claims 4
- 101150024327 UGT1 gene Proteins 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 3
- 239000000523 sample Substances 0.000 claims 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 231100000334 hepatotoxic Toxicity 0.000 claims 2
- 230000003082 hepatotoxic effect Effects 0.000 claims 2
- 239000002751 oligonucleotide probe Substances 0.000 claims 2
- 102000054765 polymorphisms of proteins Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 229940126062 Compound A Drugs 0.000 claims 1
- 238000009007 Diagnostic Kit Methods 0.000 claims 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000003752 polymerase chain reaction Methods 0.000 claims 1
- 229920001184 polypeptide Chemical group 0.000 claims 1
- 108090000765 processed proteins & peptides Chemical group 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 238000012163 sequencing technique Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- MIQPIUSUKVNLNT-UHFFFAOYSA-N tolcapone Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC(O)=C(O)C([N+]([O-])=O)=C1 MIQPIUSUKVNLNT-UHFFFAOYSA-N 0.000 claims 1
- 229960004603 tolcapone Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00115353 | 2000-07-14 | ||
| PCT/EP2001/007524 WO2002006523A2 (en) | 2000-07-14 | 2001-07-02 | Method for detecting pre-disposition to hepatotoxicity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004508017A JP2004508017A (ja) | 2004-03-18 |
| JP2004508017A5 true JP2004508017A5 (https=) | 2005-02-03 |
| JP3947103B2 JP3947103B2 (ja) | 2007-07-18 |
Family
ID=8169277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002512413A Expired - Fee Related JP3947103B2 (ja) | 2000-07-14 | 2001-07-02 | 肝細胞毒性に対する素因を検出する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040076968A1 (https=) |
| EP (1) | EP1325152A2 (https=) |
| JP (1) | JP3947103B2 (https=) |
| AU (1) | AU2001281930A1 (https=) |
| WO (1) | WO2002006523A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395481B1 (en) * | 1999-02-16 | 2002-05-28 | Arch Development Corp. | Methods for detection of promoter polymorphism in a UGT gene promoter |
| US20030099960A1 (en) * | 2001-01-26 | 2003-05-29 | The University Of Chicago | Compositions and methods for optimizing UGT2B7 substrate dosings and for predicting UGT2B7 substrate toxicity |
| DE10207971A1 (de) * | 2002-02-25 | 2003-09-11 | Norbert Dahmen | Verfahren zur Identifizierung Nebenwirkungs-relevanter Markerprofile |
| AU2003228425A1 (en) * | 2002-04-01 | 2003-10-20 | Phase-1 Molecular Toxicology, Inc. | Liver necrosis predictive genes |
| US20040203034A1 (en) * | 2003-01-03 | 2004-10-14 | The University Of Chicago | Optimization of cancer treatment with irinotecan |
| ES2308208T3 (es) | 2003-05-30 | 2008-12-01 | University Of Chicago | Metodos y composiciones para predecir la toxicidad del irinotecano. |
| US20090247475A1 (en) * | 2004-03-05 | 2009-10-01 | The Regents Of The University Of California | Methods and compositions relating to pharmacogenetics of different gene variants in the context of irinotecan-based therapies |
| WO2006027182A1 (en) * | 2004-09-06 | 2006-03-16 | Medizinische Hochschule Hannover | Methods and its kits based on ugt1a7 promoter polymorphism |
| WO2006070666A1 (ja) * | 2004-12-28 | 2006-07-06 | Takara Bio Inc. | 遺伝子多型の同時検出方法 |
| EP1790343A1 (en) * | 2005-11-11 | 2007-05-30 | Emotional Brain B.V. | Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction |
| CN106755388B (zh) * | 2016-11-24 | 2019-08-23 | 厦门艾德生物医药科技股份有限公司 | 一种改进的ARMS引物结构(Super-ARMS)及其使用方法 |
| CN108315420A (zh) * | 2018-04-04 | 2018-07-24 | 广西中医药大学附属瑞康医院 | 一种用于检测乙肝癌变多态性的试剂盒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992012987A1 (en) | 1991-01-10 | 1992-08-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | The genetic locus ugt1 and a mutation therein |
| TW221441B (https=) | 1991-01-25 | 1994-03-01 | Taiho Pharmaceutical Co Ltd | |
| JP2000508912A (ja) | 1996-04-19 | 2000-07-18 | スペクトラ バイオメディカル,インコーポレイテッド | 多型形態と複数の表現型との相関付け |
| GB2321190B (en) * | 1997-01-16 | 2000-09-20 | Britannia Pharmaceuticals Ltd | Pharmaceutical composition |
| EP1084271A2 (en) * | 1998-05-07 | 2001-03-21 | Axys Pharmaceuticals, Inc. | Genotyping the human udp-glucuronosyltransferase 1 (ugt1) gene |
-
2001
- 2001-07-02 WO PCT/EP2001/007524 patent/WO2002006523A2/en not_active Ceased
- 2001-07-02 US US10/333,108 patent/US20040076968A1/en not_active Abandoned
- 2001-07-02 EP EP01960438A patent/EP1325152A2/en not_active Withdrawn
- 2001-07-02 AU AU2001281930A patent/AU2001281930A1/en not_active Abandoned
- 2001-07-02 JP JP2002512413A patent/JP3947103B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Telatar et al. | Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening | |
| McGuire et al. | Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase. | |
| Anglicheau et al. | Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients | |
| JP4276691B2 (ja) | 男性不妊関連遺伝子プロタミン−2変異と男性不妊の診断方法 | |
| JP2004508017A5 (https=) | ||
| CA2782207A1 (en) | Polymorphisms associated with parkinson's disease | |
| WO2009036100A2 (en) | Prediction of qt prolongation based on snp genotype | |
| WO1999029903A2 (en) | Cancer susceptibility mutations of brca1 | |
| ES2252159T3 (es) | Polimorfismos en el gen humano del transportador de anion organico c (oatp-c). | |
| CN100379881C (zh) | 皮肤处理 | |
| Price et al. | Analysis of the HNF4 α gene in Caucasian Type II diabetic nephropathic patients | |
| WO2014043558A1 (en) | Methods of predicting the development of amd based on chromosome 1 and chromosome 10 | |
| JP2003500067A5 (https=) | ||
| US20130023442A1 (en) | Single nucleotide polymorphism for predicting recurrence of hepatocellular carcinoma | |
| WO2002006523A3 (en) | Method for detecting pre-disposition to hepatotoxicity | |
| Ye et al. | Identification of novel mutations of IRF6 gene in Chinese families with Van der Woude syndrome | |
| Thonglairoam et al. | Hemoglobin constant spring in bangkok: Molecular screening by selective enzymatic amplification of the α2‐globin gene | |
| US20060257850A1 (en) | Methods of treatment and diagnosis of patients with hepatitis c infection | |
| RU2005127807A (ru) | Применение нового полиморфизма в гене hsgki для диагностики гипертонии и применение генов семейства sgk для диагностики и терапии синдрома удлиненного q/t-периода | |
| JP2007516719A (ja) | 一塩基多型を含む二型糖尿病に関与するポリヌクレオチド、それを含むマイクロアレイ及び診断キット、並びにそれを利用したポリヌクレオチドの分析方法 | |
| Matsumoto et al. | Genetic diagnosis of Werner's syndrome, a premature aging disease, by mutant allele specific amplification (MASA) and oligomer ligation assay (OLA) | |
| KR101360408B1 (ko) | 좌심실비대와 연관된 단일염기다형성 및 그의 용도 | |
| JP2007014244A (ja) | 心室伝導障害または心室細動の遺伝的素因を検査する方法、およびそのための試薬 | |
| AU2001260263B2 (en) | Method and probes for the genetic diagnosis of hemochromatosis | |
| JP4348456B2 (ja) | グルココルチコイド製剤への感受性の遺伝子診断に用いることができる変異型ポリヌクレオチドおよび核酸分子 |